Literature DB >> 21784603

Influence of peripheral arterial disease and supervised walking on heart rate variability.

Anthony S Leicht1, Robert G Crowther, Jonathan Golledge.   

Abstract

OBJECTIVE: To examine the influence of peripheral arterial disease (PAD) on heart rate variability (HRV) in patients, and to examine the influence of an intense long-term (12 months) exercise program on HRV in PAD patients.
METHODS: This study involved ambulatory patients attending a local hospital and university center. Participants were twenty-five patients with diagnosed PAD and intermittent claudication and 24 healthy, age-matched adults. Interventions involved random allocation of PAD patients to 12 months of conservative medical treatment (Conservative) or medical treatment with supervised treadmill walking (Exercise). The main outcome measures were time- and frequency-domain, nonlinear HRV measures during supine rest, and maximal walking capacity prior to and following the intervention.
RESULTS: Despite significantly worse walking capacity (285 ± 190 m vs 941 ± 336 m; P < .05), PAD patients exhibited similar resting HRV to healthy adults. At the 12-month follow-up, Exercise patients exhibited a significantly greater improvement in walking capacity (183% ± 185% vs 57% ± 135%; P = .03) with similar small nonsignificant changes in HRV compared with Conservative patients.
CONCLUSIONS: The current study demonstrated that PAD patients exhibited similar resting HRV to healthy adults with 12 months of intense supervised walking producing similar HRV changes to that of conservative medical treatment. The greater walking capacity of healthy adults and PAD patients following supervised exercise does not appear to be associated with enhanced HRV.
Copyright © 2011 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21784603     DOI: 10.1016/j.jvs.2011.05.027

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  7 in total

Review 1.  Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication.

Authors:  David Hageman; Hugo Jp Fokkenrood; Lindy Nm Gommans; Marijn Ml van den Houten; Joep Aw Teijink
Journal:  Cochrane Database Syst Rev       Date:  2018-04-06

2.  Influence of regular exercise on body fat and eating patterns of patients with intermittent claudication.

Authors:  Anthony Leicht; Robert Crowther; Jonathan Golledge
Journal:  Int J Mol Sci       Date:  2015-05-18       Impact factor: 5.923

3.  Cortisol Awakening Response and Acute Stress Reactivity in First Nations People.

Authors:  Maximus Berger; Anthony Leicht; Angela Slatcher; Ann Katrin Kraeuter; Sarangan Ketheesan; Sarah Larkins; Zoltán Sarnyai
Journal:  Sci Rep       Date:  2017-01-31       Impact factor: 4.379

4.  Alterations in heart rate variability in patients with peripheral arterial disease requiring surgical revascularization have limited association with postoperative major adverse cardiovascular and cerebrovascular events.

Authors:  Karri T Utriainen; Juhani K Airaksinen; Olli J Polo; Harry Scheinin; Ruut M Laitio; Kari A Leino; Tero J Vahlberg; Tom A Kuusela; Timo T Laitio
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

5.  Complexity-Based Decoding of the Coupling Among Heart Rate Variability (HRV) and Walking Path.

Authors:  Shahul Mujib Kamal; Mohammad Hossein Babini; Ondrej Krejcar; Hamidreza Namazi
Journal:  Front Physiol       Date:  2020-11-25       Impact factor: 4.566

Review 6.  Exercise for intermittent claudication.

Authors:  Risha Lane; Amy Harwood; Lorna Watson; Gillian C Leng
Journal:  Cochrane Database Syst Rev       Date:  2017-12-26

7.  Correlates of Heart Rate Measures with Incidental Physical Activity and Cardiorespiratory Fitness in Overweight Female Workers.

Authors:  Laís Tonello; Felipe F Reichert; Iransé Oliveira-Silva; Sebastián Del Rosso; Anthony S Leicht; Daniel A Boullosa
Journal:  Front Physiol       Date:  2016-01-07       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.